Cathie Wood Intellia Therapeutics, Inc. Transaction History
Ark Investment Management LLC
- $11 Billion
- Q2 2024
A detailed history of Cathie Wood (Ark Investment Management LLC) transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Ark Investment Management LLC holds 11,595,789 shares of NTLA stock, worth $244 Million. This represents 2.36% of its overall portfolio holdings.
Number of Shares
11,595,789
Previous 10,989,282
5.52%
Holding current value
$244 Million
Previous $302 Million
14.16%
% of portfolio
2.36%
Previous 2.16%
Shares
31 transactions
Others Institutions Holding NTLA
# of Institutions
326Shares Held
88.8MCall Options Held
673KPut Options Held
865K-
Black Rock Inc. New York, NY9.6MShares$202 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.1MShares$191 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.8MShares$101 Million3.53% of portfolio
-
State Street Corp Boston, MA4.36MShares$91.7 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.3.26MShares$68.4 Million0.85% of portfolio
About Intellia Therapeutics, Inc.
- Ticker NTLA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,011,800
- Market Cap $1.6B
- Description
- Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...